SCHEMBL8364987

SCHEMBL8364987

COc1cccc(S(=O)(=O)N2CCC(Oc3ccc(C(F)(F)F)cc3)CC2)c1C(=O)NO

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 8/20 0.78
MMP2 P08253 7/20 0.78
SMN1; SMN2 Q16637 4/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
FPR2 P25090 1/20 0.48
PROKR1 Q8TCW9 1/20 0.48
TP53 P04637 1/20 0.46
MMP12 P39900 1/20 0.44
GAA P10253 1/20 0.42
LIPE Q05469 1/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8365029 0.91 MMP13 (0.70) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL8365011 0.91 MMP2 (0.63) MMP13MMP2SMN1; SMN2KMT2AMAPT
SCHEMBL5898962 0.91 MMP13 (0.72) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL8363040 0.90 MMP13 (0.75) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL8364898 0.89 MMP13 (0.72) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL8364810 0.89 MMP2 (0.62) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL5898986 0.88 MMP13 (0.69) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL8363776 0.88 MMP2 (0.60) MMP13MMP2SMN1; SMN2KMT2AMAPT
SCHEMBL5898973 0.88 MMP13 (1.00) MMP13MMP2SMN1; SMN2KMT2AMEN1
SCHEMBL5898969 0.88 MMP13 (0.82) MMP13MMP2SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003007954-A2 SULFONYL ARYL HYDROXAMATES AND THEIR USE AS MATRIX METALLOPROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2003-01-30 WO disclosed